Keyphrases
Gene Expression
100%
Systemic Sclerosis
100%
Precision Medicine
100%
Molecular Stratification
100%
Patient's Will
25%
Molecular Pathways
25%
Clinical Trials
12%
Therapeutic Agents
12%
Lesional Skin
12%
Disease Progression
12%
Therapeutic Benefits
12%
Lymphocyte Proliferation
12%
Cellcept
12%
Personalized Medicine
12%
Clinical Improvement
12%
Mycophenolate Mofetil
12%
High Risk
12%
Interstitial Lung Disease
12%
Therapeutic Response
12%
Targeted Therapy
12%
Organ Diseases
12%
Genomic Profiling
12%
Clinical Presentation
12%
Genomic Approaches
12%
Organ Involvement
12%
Autoantibodies
12%
Lesional
12%
Abatacept
12%
Molecular Subset
12%
Non-lesional
12%
Skin Samples
12%
Companion Diagnostics
12%
Clinical Cohort
12%
Pulmonary Arterial Hypertension
12%
Pathophysiological Processes
12%
Diffuse Cutaneous Systemic Sclerosis
12%
Scleroderma Renal Crisis
12%
T Lymphocyte Activation
12%
Limited Cutaneous Systemic Sclerosis
12%
Molecular Subclassification
12%
Study Validity
12%
Investigator-initiated Trials
12%
Orencia
12%
Medicine and Dentistry
Gene Expression
100%
Systemic Scleroderma
100%
Personalized Medicine
100%
Mycophenolate Mofetil
22%
Abatacept
22%
Disease Exacerbation
11%
Therapeutic Agent
11%
Treatment Response
11%
Pulmonary Hypertension
11%
Interstitial Lung Disease
11%
Gene Expression Profiling
11%
T Lymphocyte Activation
11%
Clinical Trial
11%
Lymphocyte Proliferation
11%
Scleroderma
11%
Autoantibodies
11%
Diseases
11%
Neuroscience
Gene Expression
100%
Abatacept
66%
Mycophenolate Mofetil
66%
Hypertension
33%
Lymphocyte Proliferation
33%
T Cell
33%
Autoantibodies
33%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Abatacept
66%
Gene Expression Profiling
33%
Clinical Trial
33%
Lymphocyte Proliferation
33%
T Lymphocyte Activation
33%
Autoantibodies
33%
Genomics
33%
Immunology and Microbiology
Systemic Scleroderma
100%
Gene Expression
100%
Abatacept
22%
Mycophenolate Mofetil
22%
Autoantibodies
11%
Scleroderma
11%
Lymphocyte Proliferation
11%
T Lymphocyte Activation
11%
Gene Expression Assay
11%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Mycophenolate Mofetil
22%
Abatacept
22%
Clinical Trial
11%
Disease Exacerbation
11%
Scleroderma
11%
Interstitial Lung Disease
11%
Pulmonary Hypertension
11%
Autoantibodies
11%
Diseases
11%